Nordhealth to Accelerate AI Development and DACH Localisation
Nordhealth to Accelerate AI Development and DACH Localisation
Helsinki, Finland - August 13, 2025 - Nordhealth is increasing its investments
in product development for AI and DACH localisation in 2025:
1. Accelerating the localisation of flagship veterinary practice management
software, Provet Cloud, into DACH markets: The company believes that the market
for veterinary enterprise clients in DACH is increasingly compelling.
Additionally, the company believes that the evolving differences in service
quality and profitability, between Provet Cloud, and Nordhealth's acquired DACH
legacy platform, Vetera, justify accelerating the groundwork to migrate Vetera
clients onto Provet Cloud.
2. Development of AI features across both of Nordhealth's Veterinary and Therapy
business units: Based on the early results of our AI-scribe trials in Therapy,
and an enhanced AI-roadmap across both business units, Nordhealth believes the
return on investment of AI development will justify the increased expenditure.
The total increases in product development expenditure from 2024 to 2025 are
expected to be around Euro 3.1M.
As a result of these investments, Nordhealth is revising its 2025 target for
'Adj. EBITDA - CAPEX' from 'between - Euro 2.0M and + Euro 2.0M', to 'between - Euro 4.0M and
- Euro 2.0M'.
Nordhealth's growth guidance remains unchanged: The company continues to
anticipate between 12% and 17% growth in 'Vet + Therapy recurring revenue' in
2025 compared to 2024, calculated at a constant currency rate as of December 31,
Cash and cash equivalents in the Nordhealth Group as at 30 June 2025 (including
amounts invested in money market funds), is Euro 20.5M.
A full update on the business and its growth initiatives will be provided in the
Q2 Investor Presentation on Aug 19, 2025.
For further information, please contact:
Charles MacBain, Group CEO, [email protected], +44 75 3903 2200
Alexander Cram, Group CFO, [email protected], +32 470 69 30 20
This stock announcement includes inside information pursuant to article 7 of the
EU Market Abuse Regulation and was published in accordance with section 5-12 of
the Norwegian Securities Trading Act by Alexander Cram, Group CFO on the date
and time indicated above.
About Nordhealth
Nordhealth is a publicly listed, fast-growing cloud-based healthcare SaaS
company on a mission to redefine digital healthcare. We build software that
empower veterinary and therapy professionals to provide the best possible care
experiences to their patients. Our products serve more than 60,000 veterinary
and therapy professionals across 13,000 clinics and hospitals located in over 30
countries.
Headquartered in Helsinki, Finland, Nordhealth has a solid footprint in the
Nordic region and a growing presence internationally, with 400 employees working
either remotely or from offices (collaboration hubs). Visit the company's
website at nordhealth.com (http://www.nordhealth.com).